Table 2.
Lipids that showed significant (adjusted p-value <0.05) differences in SGA group compared to controls in Cork plasma samples
| Lipids | Chemical class | Adjusted p-value | Fold change | Direction in SGA group |
|---|---|---|---|---|
| PE(P-31:0) | Glycerophospholipids | 2.89E − 03 | 1.17 | UP |
| PE(42:1) | Glycerophospholipids | 1.23E − 04 | 1.36 | UP |
| PE(36:4) | Glycerophospholipids | 9.68E − 04 | 1.18 | UP |
| PS(O-37:0) | Glycerophospholipids | 2.55E − 06 | 1.39 | UP |
| PS(41:5) | Glycerophospholipids | 1.60E − 04 | 1.36 | UP |
| PS(37:2) | Glycerophospholipids | 1.62E − 04 | 1.29 | UP |
| PS(43:6) | Glycerophospholipids | 4.64E − 04 | 1.54 | UP |
| PS(P-34:0) | Glycerophospholipids | 1.37E − 02 | 1.22 | UP |
| PC(O-42:4) | Glycerophospholipids | 1.24E − 02 | 1.15 | UP |
| PC(40:5) | Glycerophospholipids | 9.68E − 04 | 1.25 | UP |
| PC(38:6) | Glycerophospholipids | 6.68E − 05 | 1.25 | UP |
| LysoPC(16:0) | Glycerophospholipids | 8.57E − 04 | 1.15 | UP |
| PA(O-36:2) | Glycerophospholipids | 3.17E − 02 | 1.16 | UP |
| LysoPA(18:1) | Glycerophospholipids | 7.53E − 04 | 1.15 | UP |
| PI(37:1) | Glycerophospholipids | 1.99E − 04 | 1.20 | UP |
| PI(P-33:1) | Glycerophospholipids | 3.51E − 04 | 1.23 | UP |
| PGP(38:4) | Glycerophospholipids | 1.13E − 05 | 1.35 | UP |
| PGP(40:4) | Glycerophospholipids | 4.87E − 05 | 1.35 | UP |
| PG(36:6) | Glycerophospholipids | 5.94E − 04 | 1.23 | UP |
| PG(39:8) | Glycerophospholipids | 6.25E − 04 | 1.29 | UP |
| PG(38:4) | Glycerophospholipids | 6.43E − 04 | 1.20 | UP |
| CL(72:2) | Glycerophospholipids | 9.75E − 04 | 0.76 | DOWN |
| DG(44:4) | Glycerolipids | 4.25E − 02 | 1.12 | UP |
| DG(O-34:1) | Glycerolipids | 1.73E − 02 | 1.36 | UP |
| TG(64:15) | Glycerolipids | 4.84E − 04 | 0.47 | DOWN |
| N,N-dimethyl arachidonoyl amine | Fatty acyl | 6.69E − 19 | 7.86 | UP |
| N-palmitoyl valine | Fatty acyl | 8.58E − 11 | 1.99 | UP |
| 8S-hydroxy-hexadecanoic acid | Fatty acyl | 4.93E − 04 | 0.53 | DOWN |
| SM(34:1) | Sphingolipids | 6.30E − 05 | 1.25 | UP |
| Ganglioside GA2 (40:1) | Sphingolipids | 2.77E − 02 | 1.56 | UP |
| Cer(34:0) | Sphingolipids | 3.30E − 02 | 1.26 | UP |
| Cer(39:2) | Sphingolipids | 3.77E − 02 | 1.16 | UP |
| CE(17:0) | Steroids and steroid derivatives | 3.01E − 04 | 0.78 | DOWN |
CE cholesterol fatty ester; Cer Ceramide; CL Cardiolipin; DG diglyceride; LysoPA Lyso- Phosphatidylglycerophosphate; LysoPC Lyso-phosphatidylcholine; LysoPE Lyso-phosphatidylethanolamine; PA Phosphatidylglycerophosphate; PC Phosphatidylcholine; PE Phosphatidylethanolamine; PG Phosphatidylglycerol; PGP Phosphatidylglycerophosphate; PI Phosphatidylinositol; PS Phosphatidylserine; SM Sphingomyeline; TG triglyceride